AJA Pharma - Disclosures
Saudi Chemical subsidiary inks pact to secure exclusive licensing rights for cancer drug
Argaam 31/01/2023
Saudi Chemical starts manufacture, sale of ‘Panadol Extra’
Argaam 20/11/2022
Saudi Chemical subsidiary increases capital by 33%
Argaam 03/02/2019
AJA Pharma to raise capital to SAR 63 mln
Argaam 15/09/2015